Abstract
Heart muscle diseases or cardiomyopathies represent an important and heterogeneous group of cardiac diseases. Imaging is an essential pillar in assessment of the phenotypic expression of this group of diseases, indispensable for disease classification, obligatory to evaluate the degree of dysfunction, and appealing for risk stratification. This chapter focuses on the emerging role of MRI to assess this complex group of diseases. Since MRI provides unique information on myocardial tissue characteristics and functional properties, the focus is not only on the diagnosis, differential diagnosis, follow-up of disease progression, and evaluation of response to treatment of cardiomyopathies but this technique is increasingly being used for risk stratification of potential harmful complications, such as cardiac arrhythmias, heart failure, and sudden cardiac death.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abarra S, Migrino RQ, Sosnovik D, Leichter JA, Brady TJ, Holmvang G (2004) Value of fat suppression in the MRI evaluation of suspected arrhythmogenic right ventricular dysplasia. AJR 182:587–591
Abdel-Aty H, Boyé P, Zagrosek A et al (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis. Comparison of different approaches. J Am Coll Cardiol 45:1815–1822
Abdel-Aty H, Siegle N, Natusch A et al (2008) Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus 17:561–567
Abe Y, Kondo M (2002) Apical ballooning of the left ventricle: a distinct entity? Heart 89:974–976
Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H (2003) Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol 41:737–742
Abelmann WH, Lorell BH (1989) The challenge of cardiomyopathy. J Am Coll Cardiol 13:1219–1239
Adabag AS, Maron BJ, Appelbaum E et al (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369–1374
Akashi Y, Nakazawa K, Sakakibara M, Miyake F, Sasaka (2002) Reversible left ventricular dysfunction “Takotsubo” cardiomyopathy related to catecholamine cardiotoxicity. J Electrocardiol 35:351–356
Ako J, Kozaki K, Yoshizumi M, Ouchi Y (2002) Transient left ventricular apical ballooning without coronary artery stenosis: a form of stunning-like phenomenon? J Am Coll Cardiol 39:741–742
Aletras AH, Tilak GS, Hsu LY, Arai AE (2011) Heterogeneity of intramural function in hypertrophic cardiomyopathy: mechanistic insights from late gadolinium enhancement and high-resolution DENSE strain maps. Circ Cardiovasc Imaging 4:425–434
Allenore Y, Vignaux O, Arnaud L et al (2006) Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 65:249–252
Alsaileek AA, Syed I, Seward JB, Julsrud P (2008) Myocardial fibrosis of left ventricle: magnetic resonance imaging in noncompaction. J Magn Reson Imaging 27:621–624
Anderson RH (2008) Ventricular non-compaction—a frequently ignored finding? Eur Heart J 29:10–11
Anderson LJ, Holden S, Davis B et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179
Angelini A, Melacini P, Barbero F, Thiene G (1999) Evolutionary persistence of spongy myocardium in humans. Circulation 99:2475
Aretz HT, Billingham ME, Edwards WD et al (1986) Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1:3–14
Arrivé L, Assayag P, Russ G, Najmark D, Brochet E, Nahum H (1994) MRI and cine MRI of asymmetric septal hypertrophic cardiomyopathy. J Comput Assist Tomogr 18:376–382
Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985
Assomull RG, Lyne JC, Keenan N et al (2007) The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised Troponin, and unobstructed coronary arteries. Eur Heart J 28:1242–1249
Austin BA, Tang WH, Rodriguez ER et al (2009) Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. J Am Coll Cardiol Img 2:1369–1377
Awtry EH, Philippides GJ (2010) Alcohol and cocaine-associated cardiomyopathies. Prog Cardiovasc Dis 52:289–299
Baccouche H, Mahrholdt H, Meinhardt G et al (2009) Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J 30:2869–2879
Baruteau AE, Leurent G, Martins RP et al (2010) Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives. Int J Cardiol 144:143–145
Basavarajaiah S, Boraita A, Whyte G, Wilson M, Carby L, Shah A, Sharma S (2008a) Ethnic differences in left ventricular remodeling in highly-trained athletes. J Am Coll Cardiol 51:2256–2262
Basavarajaiah S, Wilson M, Whyte G, Shah A, McKenna W, Sharma S (2008b) Prevalence of hypertrophic cardiomyopathy in highly trained athletes. J Am Coll Cardiol 51:1033–1039
Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A (2000) Hypertrophic cardiomyopathy and sudden cardiac death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31:988–998
Basso C, Corrado D, Marcus FI, Nava A, Thiene G (2009) Arrhythmogenic right ventricular dysplasia. Lancet 373:1289–1300
Beer M, Weidemann F, Breunig F, Knoll A et al (2006) Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry’s cardiomyopathy. Am J Cardiol 97:1515–1518
Belanger AR, Miller MA, Donthireddi UR, Najovits AJ, Goldman ME (2008) New classification scheme of left ventricular noncompaction and correlation with ventricular performance. Am J Cardiol 102:92–96
Belenkov Y, Vikhert OA, Belichenko OI, Arabidze GG (1992) Magnetic resonance imaging of cardiac hypertrophy in malignant arterial hypertension. Am J Hypertens 5:195S–199S
Bellenger NG, Davies LC, Francis JM, Coats AJS, Pennell DJ (2000) Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2:271–278
Bello D, Shah DJ, Farah GM (2003) Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy. Circulation 108:1945–1953
Bellotti G, Bocchi EA, de Moreas A et al (1996) In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas’ heart disease. Am Heart J 131:301–317
Beltrami CA, Finato N, Rocco M et al (1995) The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 27:291–305
Benson L, Liu P, Olivieri N, Rose V, Freedom R (1989) Left ventricular function in young adults with thalassemia. Circulation 80:274
Bergler KJ, Sochor H, Stanek G, Globits S, Ullrich R, Glogar D (1993) Indium 111-monoclonal antimyosin antibody and magnetic resonance imaging in the diagnosis of acute Lyme myopericarditis. Arch Intern Med 153:2696–2700
Berkowitz SJ, Macedo R, Malayeri AA et al (2009) Axial black blood turbo spin echo imaging of the right ventricle. Magn Reson Med 61:307–314
Bhatia SR, Tu JV, Lee DS et al (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260–269
Biondi B, Kahaly GJ (2010) Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol 6:431–443
Bleyer WA (1990) The impact of childhood cancer on the United States and the world. CA Cancer J Clin 40:355–367
Bluemke DA, Kronmal RA, Lima JAC, Liu K, Olson J, Burke GL, Folsom AR (2008) The relationship of left ventricular mass and geometry to incident cardiovascular events. J Am Coll Cardiol 52:2148–2155
Bogaert J, Francone M (2009) Cardiovascular magnetic resonance in pericardial diseases. J Cardiovasc Magn Reson 11:14
Bogaert J, Goldstein M, Tannouri F, Golzarian J, Dymarkowski S (2003) Late myocardial enhancement in hypertrophic cardiomyopathy using contrast-enhanced magnetic resonance imaging. Am J Roentgenol AJR 180:981–985
Bogaert J, Taylor AM, Van Kerckhove F, Dymarkowski S (2004) Use of inversion-recovery contrast-enhanced MRI technique for cardiac imaging: spectrum of diseases. Am J Roentgenol AJR 182:609–615
Bogun FM, Desjardins B, Good E et al (2009) Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy. Utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol 53:1138–1145
Borreguero LJJ, Corti R, de Soria RF, Osende JI, Fuster V, Badimon JJ (2004) Diagnosis of isolated noncompaction of the myocardium by magnetic resonance imaging. Circulation 105:e177–e178
Boudina S, Abel ED (2010) Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11:31–39
Braunwald E, Kloner RA (1982) The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66:1146–1156
Brigden W (1957) The noncoronary cardiomyopathies. Lancet II:1179–1243
Bruder O, Schneider S, Nothnagel D et al (2009) EuroCMR (European Cardiovascular Magnetic Resonance) registry: result of the German pilot phase. J Am Coll Cardiol 54:147–1466
Bruder O, Wagner A, Jensen CJ et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56:875–887
Bulkley BH, Weisfeldt ML, Hutchins GM (1977) Asymmetric septal hypertrophy and myocardial fiber disarray. Features of normal, developing and malformed hearts. Circulation 56:292–298
Bulut A, Rav-Acha M, Aydin O et al (2009) “Inverted Tako-Tsubo”: transient apical-sparing cardiomyopathy. Int J Cardiol 134:e35–e38
Burke AP, Farb A, Tashko G, Virmani R (1998) Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium. Are they different diseases? Circulation 97:1571–1580
Buser PT, Wagner S, Auffermann W et al (1990) Three-dimensional analysis of the regional contractility of the normal and the cardiomyopathic left ventricle using cine-magnetic resonance imaging (in German). Z Kardiol 79:573–579
Captur G, Nihoyannopoulos P (2010) Left ventricular non-compaction: genetic heterogeneity, diagnosis and clinical course. Int J Cardiol 140:145–153
Carlson MD, White RD, Trohman RG et al (1994) Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging. J Am Coll Cardiol 24:720–727
Carpenter JP, He T, Kirk P et al (2011) On T2* magnetic resonance and cardiac iron. Circulation 123:1519–1528
Casolo GC, Poggesi L, Boddi M et al (1987) ECG-gated magnetic resonance imaging in right ventricular dysplasia. Am Heart J 113:1245–1248
Casolo GC, Trotta F, Rostagno C et al (1989) Detection of apical hypertrophic cardiomyopathy by magnetic resonance imaging. Am Heart J 117:468–472
Castillo E, Tandri H, Rodriguez R et al (2004) Arrhythmogenic right ventricular dysplasia: ex vivo and in vivo fat detection with black-blood MR imaging. Radiology 232:38–48
Chan PCK, Liu P, Cronin C, Heathcote J, Uldall R (1992) The use of nuclear magnetic resonance imaging in monitoring total body iron in hemodialysis patients with hemosiderosis treated with erythropoietin and phlebotomy. Am J Kidney Dis 19:484–489
Chandra M, Silverman ME, Oshinski J, Pettigrew R (1996a) Diagnosis of cardiac sarcoidosis aided by MRI. Chest 110:562–565
Chandra M, Pettigrew RI, Eley JW, Oshinski JN, Guyton RA (1996b) Cine-MRI-aided endomyocardectomy in idiopathic hypereosinophilic syndrome. Ann Thorac Surg 62:1856–1858
Charron P, Arad M, Arbustini E et al (2010) Genetic counseling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 31:2715–2726
Cheong BYC, Muthupillai R, Nemeth M et al (2009) The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 26:39–46
Choudbury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156–2164
Coelho-Filho OR, Mongeon F-P, Mitchell RN et al (2010) Löffler endocarditis presenting with recurrent polymorphic ventricular tachycardia diagnosed by cardiac magnetic resonanc imaging. Circulation 122:96–99
Cooper LT (2009) Myocarditis. N Engl J Med 360:1526–1538
Cooper LT, Baughman KL, Feldman AM et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease. A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116:2216–2233
Corrado D, Fontaine G, Marcus FI et al (2000) Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Need for an international registry. Circulation 101:e101–e106
Crilley JG, Boehm EA, Blair E et al (2003) Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 41:1776–1782
Cuspidi C, Lonati L, Sampieri L, Leonetti G, Zanchetti A (1997) Physiological versus pathological hypertrophy. The athlete and the hypertensive. In: Zanchetti A et al (eds) Hypertension and the heart. Plenum Press, New York, pp 145–158
D’Silva SA, Kohli A, Dalvi BV, Kale PA (1992) MRI in right ventricular endomyocardial fibrosis. Am Heart J 123:1390–1392
Dalal D, Tandri H, Judge DP et al (2009) Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. A genetics-magnetic resonance imaging correlation study. J Am Coll Cardiol 53:1289–1299
Davlouros PA, Danias PG, Karatza AA, Kiaffas MG, Alexopoulos D (2009) Saw-tooth cardiomyopathy. J Cardiovasc Magn Reson 16:54
Dawson DK, Maceira AM, Raj VJ, Graham C, Pennell DJ, Kilner PJ (2011) Regional thicknesses and thickening of compacted and trabeculated myocardial layers of the normal left ventricle studied by cardiovascular magnetic resonance. Circ Cardiovasc Imaging 4:139–146
De Cobelli F, Pieroni M, Esposito A et al (2006) Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 47:1649–1654
de Souza F, Altenburg R, Curi Gismondi O, Cunha Neto SH, de Mattos MA (2008) Tako-tsubo-like cardiomyopathy and extra-adrenal pheochromocytoma: case report and literature review. Clin Res Cardiol 97:397–401
Debl K, Djavidani B, Buchner S et al (2006) Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualization of focal fibrosis. Heart 92:1447–1451
Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 331:1564–1574
Dennert RM, van Paassen P, Schalla S et al (2010) Cardiac involvement in Churg-Strauss syndrome. Arthritis Rheum 62:627–634
Desmet WJR, Adriaenssens BFM, Dens JAY (2003) Apical ballooning of the left ventricle: first series in white patients. Eur Heart J 89:1027–1031
Dewey FE, Rosenthal D, Murphy DJ, Froelicher VF, Ashley EA (2008) Does size matter. Clinical applications of scaling cardiac size and function for body size. Circulation 117:2279–2287
Di Bella G, Masci PG, Ganame J, Dymarkowski S, Bogaert J (2008) Liquefaction necrosis of the mitral annulus calcification: detection and characterization with cardiac magnetic resonance imaging. Circulation 117:e292–e294
Di Bella G, Minutoli F, Mazzeo A et al (2010) MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy. AJR 195:W394–W399
Dodd JD, Holmvang G, Hoffmann U et al (2008) Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. AJR 189:974–980
Dong SJ, MacGregor JH, Crawley AP et al (1994) Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. Circulation 90:1200–1209
Dorn GWII (2007) The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49:962–970
Durand E, Mousseaux E, Coste P et al (2008) Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J 29:348–355
Edwards NC, Ferro CJ, Townend JN, Steeds RP (2007) Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance. Rheumatology 46:1208–1209
Eidem BW (2008) Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough. J Am Soc Echocardiogr 21:1290–1292
Eitel I, Behrendt F, Schindler K et al (2008) Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging. Eur Heart J 29:2651–2659
Eitel I, Lücke C, Grothoff M et al (2010) Inflammation in takotsubo cardiomyopathy: insights form cardiovascular magnetic resonance imaging. Eur Radiol 20:422–431
Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P et al (2011) Clinical characteristics and cardiovascular magnetic resonance findings in stress (Takotsubo) cardiomyopathy. JAMA 306:277–286
Elkayam U, Akhter MW, Singh H et al (2005) Pregnancy-associated cardiomyopathy. Clinical characteristics and a comparison between early and late presentation. Circulation 111:2050–2055
Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270–276
Elshershari H, Okutan V, Celiker A (2001) Isolated noncompaction of the ventricular myocardium. Cardiol Young 11:472–475
Esposito A, De Cobelli F, Perseghin G et al (2008) Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Heart 95:228–233
Falk RH, Dubrey SW (2010) Amyloid heart disease. Prog Cardiovasc Dis 52:347–361
Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343:1388–1398
Fernandez-Golfin C, Pachon M, Corros C et al (2009) Left ventricular trabeculae: quantification in different cardiac diseases and impact on left ventricular morphological and functional parameters assessed with cardiac magnetic resonance. J Cardiovasc Med 10:827–833
Finsterer J, Stöllberger C (2008) Primary myopathies and the heart. Scand Cardiovasc J 42:9–24
Finsterer J, Stöllberger C, Feichtinger H (2002) Histological appearance of left ventricular hypertrabeculation/noncompaction. Cardiology 98:162–164
Flett AS, Hayward MP, Ashworth MT et al (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis. Preliminary validation in humans. Circulation 122:138–144
Fontaine G, Fontaliran F, Frank R (1998) Arrhythmogenic right ventricular cardiomyopathies. Clinical forms and main differential diagnoses. Circulation 97:1532–1535
Forstot JZ, Overlie PA, Neufeld GK, Harmon CE, Forstot SL (1980) Cardiac complications of Wegener’s granulomatosis: a case report of complete heart block and review of the literature. Semin Arthritis Rheum 10:148–154
Francone M, Iacucci I, Mangia M, Carbone I (2010) Endomyocardial disease related to idiopathic hypereosinophilic syndrome: a cardiac magnetic resonance evaluation. Pediatr Cardiol 31:921–922
Frey N, Katus HA, Olson EN, Hill JA (2004) Hypertrophy of the heart. A new therapeutic target? Circulation 109:1580–1589
Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R (1998) Contrast-enhanced magnetic resonance imaging visualizes changes in the course of viral myocarditis. Circulation 97:1802–1809
Friedrich MG, Sechtem I, Schulz-Menger J et al (2009) Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 53:1475–1487
Frishman WH, Del Vecchio A, Sanal S, Ismail A (2003a) Cardiovascular manifestations of substance abuse part 1: cocaine. Heart 5:187–201
Frishman WH, Del Vecchio A, Sanal S, Ismail A (2003b) Cardiovascular manifestations of substance abuse part 2: alcohol, amphetamines, heroin, cannibs, and caffeine. Heart 5:253–271
Fritz J, Solaiyappan M, Tandri H et al (2005) Right ventricle shape and contraction patterns and relation to magnetic resonance imaging findings. J Comput Assist Tomogr 29:725–733
Fujita N, Duerinckx AJ, Higgins CB (1993) Variation in left ventricular regional wall stress with cine magnetic resonance imaging: normal subjects versus dilated cardiomyopathy. Am Heart J 125:1337–1345
Gagliardi MG, Bevilacqua M, Di Renzi P, Picardo S, Passariello R, Marcelletti C (1991) Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol 68:1089–1091
Galiuto L, Ranieri De Caterina A, Porfidia A et al (2010) Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in apical ballooning or Tako-Tsubo syndrome. Eur Heart J 31:1319–1327
Ganau A, Devereux RB, Roman MJ (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19:1550–1558
Gatzka CD (2002) Left ventricular hypertrophy, cardiac imaging and cardiac electric activity. J Hypertens 20:2153–2156
Gaudio C, Tanzilli G, Mazzarotto P et al (1991) Comparison of left ventricular ejection fraction by magnetic resonance imaging and radionuclide ventriculography in idiopathic dilated cardiomyopathy. Am J Cardiol 67:411–415
Gaudio C, Pelliccia F, Tanzilli G, Mazzarotto P, Cianfrocca C, Marino B (1992) Magnetic resonance imaging for assessment of apical hypertrophy in hypertrophic cardiomyopathy. Clin Cardiol 15:164–168
Germans T, Wilde AAM, Dijkmans PA et al (2006) Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 48:2518–2523
Glanzmann C, Kaufmann P, Jenni R et al (1998) Cardiac risk after mediastinal irradiation for Hodgkin’s disease. Radiother Oncol 46:51–62
Globits S, Bergler KJ, Stanek G, Ullrich R, Glogar D (1994) Magnetic resonance imaging in the diagnosis of acute Lyme carditis. Cardiology 85:415–417
Globits S, Kreiner G, Frank H et al (1997) Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia. Circulation 96:2633–2640
Goodfield NER, Bhandari S, Plant WD, Morley-Davies A, Sutherland GR (1995) Cardiac involvement in Wegener’s granulomatosis. Br Heart J 73:110–115
Grant SCD, Levy RD, Venning MC, Ward C, Brooks NH (1994) Wegener’s granulomatosis and the heart. Br Heart J 71:82–86
Gropler RJ, Beanlands RSB, Dilsizian V et al (2010) Imaging myocardial metabolic remodeling. J Nucl Med 51:88S–101S
Gujja P, Rosing DR, Tripodi DJ, Shizukuda Y (2010) Iron overload cardiomyopathy. Better understanding of an increasing disorder. J Am Coll Cardiol 56:1001–1012
Gutberlet M, Spors B, Thoma T et al (2008) Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 246:401–409
Hachulla AL, Launay D, Gaxotte V et al (2009) Cardiac magnetic imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 68:1878–1884
Haghi D, Athanasiadis A, Papavassiliu T et al (2006) Right ventricular involvement in Takotsubo cardiomyopathy. Eur Heart J 27:2433–2439
Han Y, Peters DC, Dokhan B, Manning WJ (2009) Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathy. J Magn Reson Imaging 30:967–972
Hansch A, Pfeil A, Rzanny R, Neumann T, Kaiser WA (2009) First-pass myocardial perfusion abnormalities in Churg-Strauss syndrome with cardiac involvement. Int J Cardiovasc Imaging 25:501–510
Hardy P, Henkelman RM (1989) Transverse relaxation rate enhancement caused by magnetic particles. Magn Reson Imaging 7:265–275
Harrigan CJ, Appelbaum E, Maron BJ et al (2008) Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol 101:668–673
Harrigan CJ, Peters DC, Gibson CM et al (2011) Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology 258:128–133
Harris KM, Spirito P, Maron MS et al (2006) Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage of hypertrophic cardiomyopathy. Circulation 114:216–225
Harvey WP, Segal JP, Gurel T (1964) The spectrum of primary myocardial disease. Prog Cardiovasc Dis 7:17–42
Hausse AO, Aggoun Y, Bonnet D et al (2002) Idebenone and reduced cardiac hypertrophy in Friedreich’s ataxia. Heart 87:346–349
He T, Kirk P, Firmin DN et al (2008) Multi-center transferability of a breath-hold T2 technqiue for myocardial iron assessment. J Cardiovasc Magn Reson 10:11
Heckbert SR, Post W, Pearson GDN et al (2006) Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging. J Am Coll Cardiol 48:2285–2292
Heidenreich PA, Hancock SL, Vagelos RH, Lee BK, Schnittger I (2005) Diastolic dysfunction after mediastinal irradiation. Am Heart J 150:977–982
Hill JA, Olson EN (2007) Cardiac plasticity. Mechanisms of disease. N Engl J Med 358:1370–1380
Ho CY, López B, Coelho-Filho OR (2010) Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 363:552–563
Hoedemaekers YM, Caliskan K, Majoor-Krakauer D et al (2007) Cardiac B-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J 28:2732–2737
HombachV MerkleN, Torzewski J et al (2009) Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J 30:2011–2018
Huffman C, Wagman G, Fudim M et al (2010) Reversible cardiomyopathies—a review. Transplant Proc 42:3673–3678
Hughes SE, McKenna WJ (2005) New insights into the pathology of inherited cardiomyopathy. Heart 91:257–264
Hunold P, Wieneke H, Bruder O et al (2005) Late enhancement: a new feature in MRI of arrhythmogenic right ventricular cardiomyopathy. J Cardiovasc Magn Reson 7:649–655
Huong DL, Wechsler B, Papo T et al (1997) Endomyocardial fibrosis in Behçet’s disease. Ann Rheum Dis 56:205–208
Hurst RT, Askew JW, Reuss CS et al (2006) Transient midventricular ballooning syndrome. A new variant. J Am Coll Cardiol 48:579–583
Ichinose A, Otani H, Oikawa M et al (2008) MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol 191:862–869
Iles L, Pfluger H, Phrommintikul A et al (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52:1574–1580
Imai H, Kumai T, Sekiya M et al (1992) Left ventricular trabeculae evaluated with MRI in dilated cardiomyopathy and old myocardial infarction. J Cardiol 22:83–90
Jacquier A, Thuny F, Jop B et al (2010) Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J 31:1098–1104
Jain A, Shehata ML, Stuber M et al (2010) Prevalence of left ventricular regional dysfunction in arrhythmogenic right ventricular dysplasia. A tagged MRI study. Circ Cardiovasc Imaging 3:290–297
Jefferies JL, Towbin JA (2010) Dilated cardiomyopathy. Lancet 375:752–762
Jellis C, Martin J, Narula J, Marwick TH (2010) Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol 56:89–97
Jensen PD, Jensen FT, Christensen T, Heickendorff L, Jensen LG, Ellegaard J (2001) Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload. MAGMA 12:153–166
Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL (2003) Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 101:4632–4639
Jerosch-Herold M, Sheridan DC, Kushner JD et al (2008) Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 295:H1234–H1242
Johansson B, Maceira AM, Babu-Narayan SV, Moon JC, Pennell DJ, Kilner PJ (2007) Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance. J Am Coll Cardiol 50:1294–1297
Jurcut R, Wildiers H, Ganame J, D’hooge J, Paridaens R, Voigt JU (2008) Detection and monitoring of cardiotoxicity-what does modern cardiology offer? Support Care Cancer 16:437–445
Kahan A, Allanore Y (2006) Primary myocardial involvement in systemic sclerosis. Rheumatology 45:iv14–iv17
Kalil-Filho R, de Albuquerque CP (1995) Magnetic resonance imaging in Chagas’ heart disease. Rev Paul Med 113:880–883
Kane GC, Keogh KA (2009) Involvement of the heart by small and medium vessel vasculitis. Curr Opin Rheumatol 21:29–34
Kang YJ (2003) New understanding in cardiotoxicity. Curr Opin Drug Discov Devel 6:110–116
Kawada N, Sakuma H, Yamakado T et al (1999) Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects. Radiology 21:129–135
Kellman P, Hernando D, Shah S et al (2009) Multiecho Dixon fat and water separation method for detecting fibrofatty infiltration in the myocardium. Magn Reson Med 61:215–221
Keren A, Syrris P, McKenna WJ (2008) Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 5:158–168
Khavandi K, Khavandi A, Asghar O et al (2009) Diabetic cardiomyopathy—a distinct disease? Best Pract Res Clin Endocrinol Metab 23:347–360
Kimura F, Matsuo Y, Nakajima T et al (2010) Myocardial fat at cardiac imaging: how can we differentiate pathologic form physiologic fatty infiltration. Radiographics 30:1587–1602
Kindermann I, Kindermann M, Kandolf R et al (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639–648
Kirk P, Roughton M, Porter JB et al (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 120:1961–1968
Kloner RA, Rezkalla SH (2003) Cocaine and the heart. N Engl J Med 348:487–488
Klues HG, Schiffers A, Maron BJ (1995) Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26:1699–1708
Knaapen P, Götte MJW, Paulus WJ et al (2006) Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study. Radiology 240:380–388
Knaapen P, Germans T, Camici PG et al (2008) Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 294:H986–H993
Kobayashi H, Yokoe I, Hirano M et al (2008) Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatol 36:106–112
Kohli SK, Pantazis AA, Shah JS et al (2008) Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria. Eur Heart J 29:89–95
Koito H, Suzuki J, Ohkubo N, Ishiguro Y, Iwasaka T, Inada M (1996) Gadolinium-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging of dilated cardiomyopathy: clinical significance of abnormally high signal intensity of left ventricular myocardium. J Cardiol 28:41–49
Kosovsky PA, Ehlers KH, Rafal RB, Williams WM, O’Loughlin JE, Markisz JA (1991) MR imaging of cardiac mass in Wegener granulomatosis. J Comput Assist Tomogr 15:1028–1030
Koyama J, Ray-Sequin PA, Falk RH et al (2003) Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107:2446–2452
Kramer CM, Reichek N, Ferrari VA, Theobald T, Dawson J, Axel L (1994) Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation 90:186–194
Kubo T, Gimeno JR, Bahl A et al (2007) Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. J Am Coll Cardiol 49:2419–2426
Kushwaha SS, Fallon JT, Fuster V (1997) Restrictive cardiomyopathy. N Engl J Med 336:267–276
Kwon DH, Setser RM, Thamilarasan M et al (2008) Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophy cardiomyopathy. Heart 94:1295–1301
Kwon DH, Smedira NG, Rodriguez ER et al (2009) Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy. Correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 54:242–249
Laissy JP, Messin B, Varenne O et al (2002) MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest 122:1638–1648
Lakdawala NK, Givertz MM (2010) Dilated cardiomyopathy with conduction disease and arrhythmia. Circulation 122:527–534
Lamb HJ, Beyerbacht HP, van der Laarse A et al (1999) Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 99:2261–2267
Lauschke J, Maisch B (2008) Athlete’s heart of hypertrophic cardiomyopathy? Clin Res Cardiol 98:80–88
Leonardi S, Raineri C, De Ferrari GM et al (2009) Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy. Eur Heart J 30:2003–2010
Lesnefsky EJ, Allen KG, Carrea FP, Horwitz LD (1992) Iron-cjatalyzed reactions cause lipid peroxidation in the intact heart. J Mol Cell Cardiol 24:1031–1038
Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL (1991) Clinicopathologic description of myocarditis. J Am Coll Cardiol 18:1616–1626
Lightfoot JC, D’Agostino RB, Hamilton CA et al (2010) Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model. Circ Cardiovasc Imaging 3:550–558
Lipshultz SE, Colan SD, Gelber RD et al (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808–815
Liu P, Olivieri N (1994) Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther 8:101–110
Lofiego C, Biagini E, Pasquale F et al (2007) Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart 93:65–71
Lombardi C, Rusconi C, Faggiano P, Lanzani G, Campana C, Arbustini E (1995) Successful reduction of endomyocardial fibrosis in a patient with idiopathic hypereosinophilic syndrome. A case report. Angiology 46:345–351
Lund MB, Ihlen H, Voss BM et al (1996) Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin’s disease: an echocardiographic study. Heart 75:591–595
Maceira AM, Joshi J, Prasad SK et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186–193
Maceira AM, Prasad SK, Pennell DJ, Mohiaddin RH (2008a) Integrated evaluation of the hypertensive patient with cardiovascular magnetic resonance. Int J Cardiol 125:383–390
Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ (2008b) Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 10:54–64
MacGowan GA, Shapiro EP, Azhari H et al (1997) Shortening in the fiber and cross-fiber directions in the normal human left ventricle and in idiopathic dilated cardiomyopathy. Circulation 96:535–541
Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis. A comparison to histology and molecular biology. Circulation 109:1250–1258
Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474
Mahrholdt H, Wagner A, Deluigi C et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590
Maier SE, Fischer SE, McKinnon GC, Hess OM, Kraeyenbuehl HP, Boesiger P (1992) Evaluation of left ventricular segmental wall motion in hypertrophic cardiomyopathy with myocardial tagging. Circulation 86:1919–1928
Manins V, Habersberger J, Pfluger H, Taylor AJ (2009) Cardiac magnetic resonance imaging in the evaluation of cardiac sarcoidosis: an Australian single-center experience. Int J Med 39:77–82
Marcu CB, beek AM, van Rossum AC (2007) Chagas’ heart disease diagnosed on MRI: the importance of patient “geographic” history. Int J Cardiol 1147:e58–e60
Marcus FI, McKenna WJ, Sherrill D et al (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dyplasia. Proposed modification of the task force criteria. Circulation 121:1533–1541
Mark PB, Johnston N, Groenning BA et al (2006) Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 69:1839–1845
Marmursztejn J, Vignaux O, Cohen P et al (2009) Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patients. Clin Exp Rheumatol 27:S70–S76
Marmursztejn J, Cohen P, Duboc D et al (2010) Cardiac magnetic resonance imaging in Churg-Strauss-syndrome. Impact of immunosuppressants on outcome assessed in a prospective study on 8 patients. Clin Exp Rheumatol 28(1 Suppl 57):8–13
Maron BJ (2003) Sudden death in young athletes. N Engl J Med 349:1064–1075
Maron BJ, Pelliccia A (2006) The heart of trained athletes. Cardiac remodeling and the risk of sports, including sudden death. Circulation 114:1633–1644
Maron BJ, Anan TJ, Roberts WC (1981) Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation 63:882–894
Maron BJ, Bonow RO, Cannon ROI, Leon MB (1987) Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316:780–789
Maron BJ, Pelliccia A, Spirito P (1995) Cardiac disease in young trained athletes. Insight into methods for distinguishing athlete’s heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 91:1596–1602
Maron BJ, McKenna WJ, Danielson GK et al (2003a) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol 42:1687–1713
Maron MS, Olivotto I, Betocchi S et al (2003b) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophy cardiomyopathy. N Engl J Med 348:295–303
Maron BJ, Towbin JA, Thiene G et al (2006a) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816
Maron MS, Olvitoo I, Zenovich AG et al (2006b) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232–2239
Maron MS, Hauser TH, Dubrow E et al (2007) Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol 100:1293–1298
Maron MS, Finley JJ, Bos M et al (2008a) Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 118:1541–1549
Maron MS, Appelbaum E, Harrigan CJ et al (2008b) Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 1:184–191
Maron MS, Maron BJ, Harrigan C et al (2009) Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 54:220–228
Maron MS, Olivotto I, Harrigan C et al (2011) Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation 124:40–47
Masci PG, Marinelli M, Piacenti M et al (2010a) Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy. A tagged cardiac magnetic resonance and positron emission tomography study. Circ Cardiovasc Imaging 3:482–490
Masci PG, Francone M, Desmet W et al (2010b) Right ventricular ischemic injury in patients with acute ST-segment elevation myocardial infarction. Characterization with cardiovascular magnetic resonance. Circulation 122:1405–1412
Matoh F, Satoh H, Shiraki K et al (2007) Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Cardiac Fail 13:372–379
Matoh F, Satoh H, Shiraki K et al (2008) The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J Cardiol 51:179–188
Matsuki M, Matsuo M (2000) MR findings of myocardial sarcoidosis. Clin Radiol 55:323–325
Matsuoka H, Hamada M, Honda T et al (1993) Precise assessment of myocardial damage associated with secondary cardiomyopathies by use of Gd-DTPA-enhanced magnetic resonance imaging. Angiology 44:945–950
Mavrogeni S, Gotsis E, Verganelakis D et al (2009) Effect of iron overload on exercise capacity in thalassemic patients with heart failure. Int J Cardiovasc Imaging 25:777–783
Maya L, Villarreal FJ (2010) Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis. J Moll Cell Cardiology 48:524–529
Mazur W, Nagueh SF, Lakkis NM et al (2001) Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 103:1492–1496
McCann GP, Van Dockum WG, Beek AM et al (2007) Extent of myocardial infarction and reverse remodeling assessed by cardiac magnetic resonance in patients with and without right bundle branch block following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol 99:563–567
McCrohon JA, Richmond DR, Pennell DJ, Mohiaddin RH (2002) Isolated noncompaction of the myocardium. A rarity or missed diagnosis? Circulation 106:e22–e23
McCrohon JA, Moon JCC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59
McKenna WJ, Thiene G, Nava A et al (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 71:215–218
Meijs MFL, Bots ML, Vonken E-JA et al (2007) Rationale and design of the SMART Heart study. A prediction model for left ventricular hypertrophy in hypertension. Neth Heart J 15:295–298
Mekinian A, Lions C, Leleu X et al (2010) Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging. Am J Med 123:864–868
Melacini P, Basso C, Angelini A et al (2010) Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J 31:2111–2123
Meyer C, Schmid G, Görlitz S et al (2007) Cardiomyopathy in Friedreich’s ataxia—assessment by cardiac MRI. Mov Disord 22:1615–1622
Migrino RQ, Christenson R, Szabo A, Bright M, Truran S, Hari P (2009) Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow-up. BMC Med Phys 9:5–11
Miller MA, Gomes JA, Fuster V (2007) Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy. Nat Clin Pract Cardiovasc Med 4:667–676
Minami Y, Kajimoto K, Terajima Y et al (2011) Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 57:2346–2355
Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH (2008) A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med 359:43–49
Mollet NR, Dymarkowski S, Volders W et al (2002) Visualization of ventricular thrombi with contrast-enhanced MRI in patients with ischemic heart disease. Circulation 106:2873–2876
Moon JCC, McKenna WJ, McCrohon JA, Elliot PM, Smith GC, Pennell DJ (2003a) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1561–1567
Moon JCC, Mundy HR, Lee PJ, Mohiaddin RH, Pennell DJ (2003b) Myocardial fibrosis in glycogen storage disease type III. Circulation 107:e47
Moon JCC, Sachdev B, Elkington AG et al (2003c) Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24:2151–2155
Moon JC, Fisher NG, McKenna WJ, Pennell DJ (2004a) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90:645–649
Moon JC, Reed E, Sheppard MN et al (2004b) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:2260–2264
Moon JC, Sheppard M, Reed E et al (2006) The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 8:479–482
Moreo A, Ambrosio G, De Chiara B et al (2009) Influence of myocardial fibrosis on left ventricular diastolic function. Noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2:437–443
Morganroth J, Maron BJ, Henry WL, Epstein SE (1975) Comparative left ventricular dimensions in trained athletes. Ann Intern Med 82:521–524
Motoyasu M, Kurita T, Onishi K et al (2008) Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging. Circ J 72:378–383
Munk PS, ∅rn S, Larsen AI (2007) Lyme carditis: persistent local delayed enhancement by cardiac magnetic resonance imaging. Int J Cardiol 115:e108–e110
Myrehaug S, Pintelie M, Yun L et al (2010) A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease. Blood 116:2237–2240
Nagueh SF, Mahmarian JJ (2006) Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 48:2410–2422
Naik M, Kim D, O’Brien F, Axel L, Srichai MB (2008) Images in cardiovascular medicine. Lyme carditis. Circulation 118:1881–1884
Nassenstein K, Breuckmann F, Huger M et al (2008) Detection of myocardial fibrosis in systemic sclerosis by contrast-enhanced magnetic resonance imaging. Rofo 180:1054–1060
Nathwani D, Hamlet N, Walker E (1990) Lyme disease: a review. Br J Gen Pract 40:72–74 (see comments)
Naylor LH, George K, O’Driscoll G, Green DJ (2008) The athlete’s heart: a contemporary appraisal of the ‘Morganroth hypothesis’. Sports Med 38:69–90
Nazarian S, Bluemke DA, Lardo AC et al (2005) Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112:2821–2825
Neumann T, Manger B, Schmid M et al (2009) Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) 88:236–243
Ng AC, Delgado V, Bertini M et al (2010) Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation 122:2538–2544
Nihoyannopoulos P, Dawson D (2009) Restrictive cardiomyopathies. Eur J Echocardio 10:iii23–iii33
Niida T, Isoda K, Sasaki M et al (2008) Late gadolinium enhanced high resolution magnetic resonance imaging reveals pathophysiological condition of cardiac sarcoidosis. Int Heart J 50:263–266
Norman M, Simpson M, Mogensen J et al (2005) Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation 112:636–642
Nucifora G, Aquaro GD, Pingitore A, Masci PG, Lombardi M (2011) Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Failure 13:170–176
O’Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874
O’Neill SG, Woldman S, Bailliard F et al (2009) Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis 68(9):1478–1481
Oechslin E, Jenni R (2011) Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity? Eur Heart J 32:1446–1456
Oechslin EN, Attenhofer Jost CH, Rojas JR et al (2000) Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 36:493–500
Ohira H, Tsujino I, Ishimaru S (2008) Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 35:933–941
Olivotto I, Maron MS, Autore C et al (2008) Assessment and significance of left ventricular mass by magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 52:559–566
Olivotto I, Maron BJ, Appelbaum E et al (2010) Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol 106:261–267
Ong P, Athansiadis A, Hill S et al (2011) Usefulness of pericardial effusion as new diagnostic criterion for noninvasive detection of myocarditis. Am J Cardiol 108:445–452
Otmani A, Leborgne L, Renard C et al (2007) Electrocardiogram, electrocardiography, and magnetic resonance imaging characteristics in Uhl’s disease. Circulation 115:e11–e12
Owan TE, Hodge DO, Herges RM et al (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259
Pamuru PR, Dokuparthi MVN, Remersu S, Calambur N, Nallari P (2010) Comparison of Uhl’s anomaly, right ventricular outflow tract ventricular tachycardia (RVOT VT) and arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) with an insight into genetics of ARVD/C. Indian J Med Res 131:35–45
Park JH, Kim YM, Chung JW, Park YB, Han JH, Han MC (1992) MR imaging of hypertrophic cardiomyopathy. Radiology 185:441–446
Parrillo JE (1990) Heart disease and the eosinophil. N Engl J Med 323:1560–1561
Patel MR, Cawley PJ, Heitner JF et al (2009) Detection of myocardial sarcoidosis in patients with sarcoidosis. Circulation 120:1969–1977
Petersen SE, Selvanayagam JB, Francis JM et al (2005a) Differentiation of athlete’s heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 7:551–558
Petersen SE, Selvanayagam JB, Wiesmann F et al (2005b) Left ventricular non-compaction. Insight from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 46:101–105
Petersen SE, Jerosch-Herold M, Hudsmith LE (2007) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy. New insights from multiparametric magnetic resonance imaging. Circulation 115:2418–2425
Pfluger HB, Phrommintikul A, Mariani JA, Cherayath JG, Taylor AJ (2008) Utility of myocardial fibrosis and fatty infiltration detected by cardiac magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular dysplasia–a single centre experience. Heart Lung Circ 17:478–483
Pieroni M, Dello Russo A, Marzo F et al (2009) High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy. Differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy. J Am Coll Cardiol 53:681–689
Pignatelli RH, McMahon CJ, Dreyer WJ et al (2003) Clinical characterization of left ventricular noncompaction in children. A relatively common form of cardiomyopathy. Circulation 108:2672–2678
Pinamonti B, Dragos AM, Pyxaras SA et al (2011) Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. Eur Heart J 32:1105–1113
Pitt M, Davies MK, Brady AJ (1996) Hypereosinophilic syndrome: endomyocardial fibrosis. Heart 76:377–378
Pluim BM, Zwinderman AH, van der Laarse A, van der Wall EE (1999) The athlete’s heart. A meta-analysis of cardiac structure and function. Circulation 100:336–344
Prasad A, Lerman A, Rihal CS (2008) Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 155:408–417
Prasad A, Hastings JL, Shibata S et al (2010) Characterization of static and dynamic left ventricular function in patients with heart failure with a preserved ejection fraction. Circ Heart Fail 3:617–626
Proclemer A, Basadonna PT, Slavich GA, Miani D, Fresco C, Fioretti PM (1997) Cardiac magnetic resonance imaging findings in patients with right ventricular outflow tract premature contractions. Eur Heart J 18:2002–2010
Rademakers FE, Bogaert J (2006) Cardiac dysfunction in heart failure with normal ejection fraction: MRI measurements. Prog Cardiovasc Dis 49:215–227
Rademakers FE, Buchalter MB, Rogers WJ et al (1992) Dissociation between left ventricular untwisting and filling. Accentuation by catecholamines. Circulation 85:1572–1581
Rademakers FE, Marchal G, Mortelmans L, Van de Werf F, Bogaert J (2003) Evolution of regional performance after an acute anterior myocardial infarction in humans using magnetic resonance tagging. J Physiol 546:777–787
Rahman JE, Helou EF, Gelzer-Bell R (2004) Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 43:410–415
Raman SV, Basso C, Tandri H, Taylor MRG (2010) Imaging phenotype vs genotype in nonhypertrophic heritable cardiomyopathies. Dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Imaging 3:753–765
Rapezzi C, Merline G, Quarta C et al (2009) Systemic cardiac amyloidosis. Disease profiles and clinical courses of the 3 main types. Circulation 120:1203–1212
Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842
Rickers C, Wilke N, Jerosch-Herold M et al (2005) Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112:855–861
Rijzewijk LJ, van der Meer RW, Smit JW et al (2008) Myocardial steatosis is an independenet predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 52:1793–1799
Ripoli A, Pingitore A, Favilli B et al (2005) Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol 45:439–445
Rochitte CE, Nacif MD, de Oliveira Junior AC et al (2007) Cardiac magnetic resonance in Chagas’ disease. Artif Organs 31:259–267
Ruberg FL, Appelbaum E, Davidoff R et al (2009) Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 103:544–549
Rubinshtein R, Glockner JF, Ommen SR et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 3:51–58
Rudin M, Pedersen B, Umemura K, Zierhut W (1991) Determination of rat heart morphology and function in vivo in two models of cardiac hypertrophy by means of magnetic resonance imaging. Basic Res Cardiol 86:165–174
Rudolf A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy. Relation to remodeling. J Am Coll Cardiol 53:284–291
Scharlag J, Schneider G, Urhausen A, Rochette V, Kramann B, Kindermann W (2002) Athete’s heart. Right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 40:1856–1863
Schietinger BJ, Brammer GM, Wang H et al (2008) Patterns of late gadolinium enhancement in chronic hemodialysis patients. J Am Coll Cardiol Img 1:450–456
Schulz-Menger J, Strohm O, Waigand J, Uhlich F, Dietz R, Friedrich MG (2000a) The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation 101:1764–1766
Schulz-Menger J, Strohm O, Dietz R, Friedrich MG (2000b) Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging. MAGMA 11:82–83
Schulz-Menger J, Abdel-Aty H, Busjahn A et al (2006) Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 8:741–746
Schwefer M, Aschenbach R, Heidemann J, Mey C, Lapp H (2009) Constrictive pericarditis, still a diagnostic challenge: comprehensive review of clinical management. Eur J Cardiohoracic Surg 36:502–510
Semelka RC, Tomei E, Wagner S et al (1990) Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J 119:1367–1373
Sen-Chowdhry S, Prasad SK, Syrris P et al (2006) Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited. Comparison with task force criteria and genotype. J Am Coll Cardiol 48:2132–2140
Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ (2007) Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 115:1710–1720
Sen-Chowdhry S, Syrris P, Prasad SK et al (2008) Left dominant arrhythmogenic cardiomyopathy. An underrecognized clinical entity. J Am Coll Cardiol 52:2175–2187
Sen-Chowdhry S, Syrris P, Pantazis A et al (2010) Mutational heterogeneity, modifier genes, and environmental influence to phenotypic diversity of arrhythmogenic cardiomyopathy. Circ Cardiovasc Genet 3:323–330
Sharkey SW, Lesser JR, Zenovich AG et al (2005) Acute and reversible cardiomyopathy provoked by stress in women form the United States. Circulation 111:472–479
Sharma OP (2003) Diagnosis of cardiac sarcoidosis. An imperfect science, a hesitant art. Chest 123:18–19
Shimada T, Shimada K, Sakane T et al (2001) Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 110:520–527
Shimizu I, Iguchi N, Watanabe H et al (2010) Delayed cardiovascular magnetic resonance as a novel technique to predict cardiac events in dilated cardiomyopathy patients. Int J Cardiol 142:224–229
Sigwart U (1995) Non-surgical reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211–214
Silva MC, Meira ZM, Giannetti G et al (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49:1874–1879
Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211
Simonetti OP, Kim RJ, Fieno DS et al (2001) An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218:215–223
Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339:900–905
Singh JA, Woodard PK, Davilla-Roman VG et al (2005) Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report. Lupus 14:137–144
Sliwa K, Flett J, Elkayam Y (2006) Peripartum cardiomyopathy. Lancet 368:687–693
Smedema JP, Snoep G, van Kroonenburgh MPG et al (2005) Evaluation of the accuracy of gadolinium-enhanced magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683–1690
Smith SC, Ladenson JH, Mason JW, Jaffe AS (1997) Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95:163–168
Soler R, Rodriguez E, Rodriguez JA, Perez ML, Penas M (1997) Magnetic resonance imaging of apical hypertrophic cardiomyopathy. J Thorac Imaging 12:221–225
Soriano CJ, Ridocci F, Estornell J, Jimenez J, Martinez V, De Velasco JA (2005) Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 45:743–748
Sotgia B, Sciagrà R, Olivotto I et al (2008) Spatial resolution between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. J Nucl Med 49:1090–1096
Sparrow P, Amirabadi A, Sussman MS, Paul N, Merchant N (2009) Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis. J Magn Reson Imaging 30:942–946
Spirito P, Seidman CE, MCKenna WJ, Maron BK (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336:775–785
Stanek G, Gray J, Strie F, Wormser G (2004) Lyme borreliosis. Lancet Infect Dis 4:197–198
Stark DD, Mosely ME, Bacon BR et al (1985) Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 154:137–142
Stensaeth KH, Fossum E, Hoffmann P et al (2010) Takotsubo cardiomyopathy in acute coronary syndrome; clinical features and contribution of cardiac magnetic resonance during the acute and convalescent phase. Scand Cardiovasc J 45:77–85
Steward S, Mason D, Braunwald E (1968) Impaired rate of left ventricular filling in idiopathic hypertrophic subaortic stenosis and valvular aortic stenosis. Circulation 37:8–14
Stöllberger C, Blazek G, Wegner C, Winkler-Dworak M, Finsterer J (2011) Neuromuscular and cardiac comorbidity determines survival in 140 patients with left ventricular hypertrabeculation/noncompaction. Int J Cardiol 148:120–123
Storey P, Thompson AA, Carqueville CL et al (2007) R2* imaging at 3T and comparison with 1.5. J Magn Reson Imaging 25:540–547
Strohm O, Schulz-Menger J, Pilz B, Osterziel KJ, Dietz R, Friedrich MG (2001) Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging 13:367–371
Stuber M, Scheidegger MB, Fischer SE et al (1999) Alterations in the local myocardial motion pattern in patients suffering from pressure overload due to aortic stenosis. Circulation 100:361–368
Sueyoshi E, Sakamoto I, Uetani M (2010) Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study. AJR Am J Roentgenol 294:W293–W298
Suk T, Edwards C, Hart H, Christiansen JP (2008) Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients. Heart Lung Circ 17:370–374
Sun JP, James KB, Yang XS et al (1997) Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities. Am J Cardiol 80:1583–1587
Suzuki J, Caputo GR, Masui T, Chang JM, O’Sullivan M, Higgins CB (1991) Assessment of right ventricular diastolic and systolic function in patients with dilated cardiomyopathy using cine magnetic resonance imaging. Am Heart J 122:1035–1040
Suzuki J, Watanabe F, Takenaka K et al (1993) New subtype of apical hypertrophic cardiomyopathy identified with nuclear magnetic resonance imaging as an underlying cause of markedly inverted T waves. J Am Coll Cardiol 22:1175–1181
Syed IS, Prasad A, Oh JK (2008) Apical ballooning syndrome or aborted acute myocardial infarction? Insights from cardiovascular magnetic resonance imaging. Int J Cardiovasc Imaging 24:875–882
Syed IS, Glockner JF, Feng DL et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. J Am Coll Cardiol Img 3:155–164
Takenaka T, Teraguchi H, Yoshida A et al (2008) Terminal stage cardiac findings in patient with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol 51:50–59
Tan YT, Wenzelburger F, Lee E et al (2009) The pathophysiology of heart failure with normal ejection fraction. Exercise echocardiography reveals complex abnormalities of both systolic and diastolic function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol 54:36–46
Tandri H, Calkins H, Nasir K et al (2003) Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 14:476–482
Tandri H, Bluemke DA, Ferrari VA et al (2004) Findings on magnetic resonance imaging of idiopathic right ventricular outflow tachycardia. Am J Cardiol 94:1441–1445
Tandri H, Saranathan M, Rodriguez ER et al (2005) Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 45:98–103
Tandri H, Castillo E, Ferrari VA et al (2006) Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia. Sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 48:2277–2284
Tanner MA, Galanello R, Dessi C et al (2007) A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 115:1876–1884
Thaman R, Gimeno JR, Reith S et al (2004) Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy. J Am Coll Cardiol 44:398–405
Tigen K, Karaahmet T, Kirma C et al (2010) Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy. J Am Soc Echocardiogr 23:416–422
To A, De Zoysa J, Christiansen JP (2007) Cardiomyopathy associated with Wegener’s granulomatosis. Heart 93:984
Tsukihashi K, Ueshima K, Uchida T et al (2001) Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. J Am Coll Cardiol 38:11–18
Ueyama T, Kasamatsu K, Hano T, Yamamoto K, Tsuruo Y, Nishio I (2002) Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors. A possible animal of Tako-Tsubo cardiomyopathy. Circ J 66:712–713
Uhl HSM (1952) A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bull Johns Hopkins Hosp 91:197–205
Valeti US, Nishimura RA, Holmes DR et al (2007) Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 49:350–357
van der Linde MR (1991) Lyme carditis: clinical characteristics of 105 cases. Scand J Infect Dis Suppl 77:81–84
van Dockum WG, ten Gate FJ, ten Berg JM et al (2004) Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43:27–34
van Dockum WG, Beek AM, ten Gate FJ et al (2005) Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111:2503–2508
van Dockum WG, Kuijer JPA, Götte MJW et al (2006) Septal ablation in hypertrophic cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis. Eur Heart J 27:2833–2839
Van Geluwe F, Dymarkowski S, Crevits I, De Wever W, Bogaert J (2006) Amyloidosis of the heart and respiratory system. Eur Radiol 16:2358–2365
Varnava AM, Elliot PM, Sharma S, McKenna WJ, Davies MJ (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476–482
Varnava AM, Elliot PM, Mahon N, Davies MJ, McKenna WJ (2001) Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 88:275–279
Vermes E, Strohm O, Otmani A et al (2011) Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. J Am Coll Cardiol Img 4:282–287
Vignaux O, Dhote R, Duboc D et al (2002a) Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 26:762–767
Vignaux O, Dhote R, Duboc D et al (2002b) Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis. A 1-year follow-up study. Chest 122:1895–1901
Virmani R, Bures JC, Roberts WC (1980) Cardiac sarcoidosis: a major cause of sudden death in young individuals. Chest 77:423–428
Vogel M, Anderson LJ, Holden S, Deanfield JE, Pennell DJ, Walker JM (2003) Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload. Eur Heart J 24:113–119
Vogelsang TW, Hanel B, Kristoffersen US et al (2008) Effect of eight weeks of endurance training on right and left ventricular volume and mass in untrained obese subjects: a longitudinal study. Scand J Med Sci Sports 18:354–359
Vogelsberg H, Mahrholdt H, Deluigi C et al (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis. J Am Coll Cardiol 51:1022–1030
Voigt A, Elgeti T, Durmus T et al (2011) Cardiac magnetic resonance imaging in dilated cardiomyopathy in adults—towards identification of myocardial inflammation. Eur Radiol 21:925–935
Von Hoff D, Layard M, Basa P (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710–717
Wassmuth R, Lentzsch S, Erbruegger U et al (2001) Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging–a pilot study. Am Heart J 141:1007–1013
Wassmuth R, Göbel U, Natusch A et al (2008) Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. J Card Fail 14:856–860
Watkins H, Ashrafian H, Redwood C (2011) Inherited cardiomyopathies. N Engl J Med 364:1643–1656
Weidemann F, Niemann M, Breunig F et al (2009) Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy. Evidence for a better outcome with early treatment. Circulation 119:524–529
Weller PF, Bubley GJ (1994) The idiopathic hypereosinophilic syndrome. Blood 83:2759–2779
Westermann D, Kasner M, Steendijk P et al (2008) Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 117:2051–2060
Westwood M, Anderson LJ, Firmin DN et al (2003a) A single breath-hold multi-echo T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imag 18:33–39
Westwood M, Anderson LJ, Firmin DN et al (2003b) Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imag 18:616–620
White RD, Trohman RG, Flamm SD et al (1998) Right ventricular arrhythmia in the absence of arrhythmogenic dysplasia: MR imaging of myocardial abnormalities. Radiology 207:743–751
White J, Sutton T, Kerr A (2010) Isolated primary cardiac sarcoidosis. MRI diagnosis and monitoring of treatment response with cardiac enzymes. Circ Heart Fail 3:e28–e29
World Health Organization Expert Committee (1984) Chagas disease. In: World Health Organization technical report series 697. WHO, Geneva, pp 50–55
Wu E, Judd RM, Vargas JD et al (2001) Visualisation of the presence, location and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357:21–28
Wu KC, Weiss RG, Thiemann DR et al (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51:2414–2421
Yared K, Johri AM, Soni AV et al (2008) Cardiac sarcoidosis imitating arrhythmogenic right ventricular dysplasia. Images in cardiovascular medicine. Circulation 118:e113–e115
Yelgec NS, Dymarkowski S, Ganame J, Bogaert J (2007) Value of MRI in patients with a clinical suspicion of acute myocarditis. Eur Rad 17:2211–2217
Yilmaz A, Mahrholdt H, Athanasiadis A et al (2008a) Coronary spasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart 94:1456–1463
Yilmaz A, Gdynia H-J, Baccouche H et al (2008b) Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 10:50
Yilmaz A, Kindermann I, Kindermann M et al (2010) Comparative evaluation of left and right ventricular endomyocardial biopsy. Differences in complication rate and diagnostic performance. Circulation 122:900–909
Yoon GJ, Telli ML, Kao DP et al (2010) Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally? J Am Coll Cardiol 56:1644–1650
Young AA, Kramer CM, Ferrari VA, Axel L, Reichek N (1994) Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy. Circulation 90:854–867
Zagrosek A, Wassmuth R, Abdel-Aty H et al (2008) Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis–a CMR study. J Cardiovasc Magn Reson 10:19
Zagrosek A, Abdel-Aty H, Boyé P et al (2009) Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. J Am Coll Cardiol Img 2:131–138
Zile MR, Baicu CF, Gaasch WH (2004) Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350:1953–1959
Zinzani PL, Gherlinzoni F, Piovaccari G et al (1996) Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin’s disease patients. Haematologica 81:132–137
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bogaert, J., Taylor, A.M. (2011). Heart Muscle Diseases. In: Bogaert, J., Dymarkowski, S., Taylor, A., Muthurangu, V. (eds) Clinical Cardiac MRI. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_358
Download citation
DOI: https://doi.org/10.1007/174_2011_358
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-23034-9
Online ISBN: 978-3-642-23035-6
eBook Packages: MedicineMedicine (R0)